Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.
暂无分享,去创建一个
Marius Wernig | T. Südhof | Marius Wernig | Yingsha Zhang | ChangHui Pak | T. Danko | Jason Aoto | Thomas C Südhof | Jason Aoto | S. Maxeiner | Stephan Maxeiner | Yingsha Zhang | Fei Yi | Tamas Danko | ChangHui Pak | Garret Anderson | Garret R. Anderson | Fei Yi
[1] T. Südhof,et al. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. , 1992, Science.
[2] Laurent Mottron,et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia , 2011, Human Genetics.
[3] K. Kinzler,et al. Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. , 2004, Nucleic acids research.
[4] O. Brüstle,et al. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration , 2009, Proceedings of the National Academy of Sciences.
[5] T. Südhof,et al. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. , 2002, Genomics.
[6] T. Südhof,et al. Cartography of neurexins: More than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons , 1995, Neuron.
[7] R. Straub,et al. Incomplete penetrance of NRXN1 deletions in families with schizophrenia , 2014, Schizophrenia Research.
[8] J. Doherty,et al. Recent genomic advances in schizophrenia , 2012, Clinical genetics.
[9] T. Südhof,et al. Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] Fred H. Gage,et al. Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.
[11] Wei Xu,et al. Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development , 2012, Proceedings of the National Academy of Sciences.
[12] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[13] A. Kaur,et al. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. , 2002, Genomics.
[14] Zhiping P. Pang,et al. Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission , 2012, Neuron.
[15] E. Banks,et al. De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.
[16] T. Südhof,et al. Autonomous Function of Synaptotagmin 1 in Triggering Synchronous Release Independent of Asynchronous Release , 2005, Neuron.
[17] M. Shaw,et al. CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes , 2010, European Journal of Human Genetics.
[18] Yiping Shen,et al. Deletions of NRXN1 (Neurexin-1) Predispose to a Wide Spectrum of Developmental Disorders , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[19] Eric S. Lander,et al. A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.
[20] K. Eggan,et al. Constructing and Deconstructing Stem Cell Models of Neurological Disease , 2011, Neuron.
[21] M. State,et al. Recent developments in the genetics of autism spectrum disorders. , 2013, Current opinion in genetics & development.
[22] Thomas C. Südhof,et al. Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing , 2014, Proceedings of the National Academy of Sciences.
[23] Patrick F Sullivan,et al. The genomics of schizophrenia: update and implications. , 2013, The Journal of clinical investigation.
[24] W. Regehr. Short-term presynaptic plasticity. , 2012, Cold Spring Harbor perspectives in biology.
[25] Brian E. McIntosh,et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy , 2011, Proceedings of the National Academy of Sciences.
[26] Zhiping P. Pang,et al. Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines , 2007, Proceedings of the National Academy of Sciences.
[27] T. Südhof,et al. Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments , 2009, Proceedings of the National Academy of Sciences.
[28] T. Südhof,et al. Calmodulin Suppresses Synaptotagmin-2 Transcription in Cortical Neurons* , 2010, The Journal of Biological Chemistry.
[29] T. Südhof,et al. Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.
[30] V. Eapen,et al. Balance within the Neurexin Trans-Synaptic Connexus Stabilizes Behavioral Control , 2014, Front. Hum. Neurosci..
[31] G. Kirov,et al. Analysis of copy number variations at 15 schizophrenia-associated loci , 2014, The British journal of psychiatry : the journal of mental science.
[32] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[33] M. Tomishima,et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.
[34] Thomas Vierbuchen,et al. Induction of human neuronal cells by defined transcription factors , 2011, Nature.
[35] S. Christian,et al. Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum , 2008 .
[36] T. Südhof,et al. α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.
[37] Marius Wernig,et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.
[38] T. Südhof,et al. CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] Krishanu Saha,et al. Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.
[40] J. Lieberman,et al. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response , 2010, Human psychopharmacology.
[41] Prashant Mali,et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. , 2009, Cell stem cell.
[42] J. Lieberman,et al. The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response , 2011, Schizophrenia Research.
[43] T. Südhof,et al. Deletion of CASK in mice is lethal and impairs synaptic function , 2007, Proceedings of the National Academy of Sciences.
[44] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[45] T. Südhof. Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.
[46] Christian Rosenmund,et al. Definition of the Readily Releasable Pool of Vesicles at Hippocampal Synapses , 1996, Neuron.
[47] S. Antonarakis,et al. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[48] A. Consiglio,et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.
[49] H. Okano,et al. Modeling human neurological disorders with induced pluripotent stem cells , 2014, Journal of neurochemistry.